Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets Cytek Muse Micro The Cytek® ...

Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology GERMANTOWN, MARYLAND / ACCESS Newswire / March 4, 2025 /uBriGene Biosciences (uBriGene), a leading cell and ...

Results from a Mass Eye and Ear-led phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at ...

Teknova & Pluristyx introduce proprietary PluriFreeze cryopreservation system to accelerate the development of cell therapies: Hollister, California Friday, March 21, 2025, 13:00 ...

Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 ...

Mass General Brigham’s Gene and Cell Therapy Institute is helping to translate ... Li (MEE), Alex Gauthier (MEE), Helene Negre (DFCI), Kit L. Shaw (DFCI), Diego E. Hernandez Rodriguez (DFCI ...

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced it will be presenting next week at Terrapinn’s Advanced Therapies Congress 2025, held in London. Ibon ...

Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell analyzer ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...